Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
Huntington’s Disease (HD) is a hereditary neurodegenerative disorder caused by the expansion of a CAG triplet repeat in the <i>HTT</i> gene, resulting in the production of an aberrant huntingtin (Htt) protein. The mutant protein accumulation is responsible for neuronal dysfunction and ce...
Main Authors: | Francesco D’Egidio, Vanessa Castelli, Annamaria Cimini, Michele d’Angelo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/12/3/571 |
Similar Items
-
Therapeutic advances in neural regeneration for Huntington's disease
by: Francesco D'Egidio, et al.
Published: (2024-01-01) -
Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila
by: Susanna Campesan, et al.
Published: (2023-09-01) -
Emerging Roles of Exosomes in Huntington’s Disease
by: Hanadi Ananbeh, et al.
Published: (2021-04-01) -
Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?
by: José Bono-Yagüe, et al.
Published: (2020-07-01) -
The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease
by: Elisabeth Singer, et al.
Published: (2021-03-01)